News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,009 Results
Type
Article (52070)
Company Profile (132)
Press Release (592797)
Multimedia
Podcasts (104)
Webinars (16)
Section
Business (175218)
Career Advice (2750)
Deals (32804)
Drug Delivery (126)
Drug Development (80071)
Employer Resources (163)
FDA (15319)
Job Trends (13938)
News (312226)
Policy (33243)
Tag
Academia (2794)
Academic (1)
Accelerated approval (29)
Adcomms (35)
Allergies (130)
Alliances (50781)
ALS (171)
Alzheimer's disease (1715)
Antibody-drug conjugate (ADC) (291)
Approvals (15472)
Artificial intelligence (485)
Autoimmune disease (127)
Automation (31)
Bankruptcy (346)
Best Places to Work (11123)
BIOSECURE Act (22)
Biosimilars (180)
Biotechnology (88)
Bladder cancer (146)
Brain cancer (59)
Breast cancer (603)
Cancer (4539)
Cardiovascular disease (392)
Career advice (2326)
Career pathing (39)
CAR-T (281)
CDC (56)
Cell therapy (717)
Cervical cancer (33)
Clinical research (67737)
Collaboration (1544)
Company closure (4)
Compensation (979)
Complete response letters (59)
COVID-19 (2915)
CRISPR (89)
C-suite (730)
Cystic fibrosis (130)
Data (5725)
Decentralized trials (2)
Denatured (20)
Depression (127)
Diabetes (478)
Diagnostics (6401)
Digital health (35)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (227)
Drug pricing (189)
Drug shortages (33)
Duchenne muscular dystrophy (222)
Earnings (62896)
Editorial (60)
Employer branding (22)
Employer resources (151)
Events (88726)
Executive appointments (965)
FDA (18073)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (19)
Funding (1297)
Gene editing (187)
Generative AI (42)
Gene therapy (589)
GLP-1 (1049)
Government (5058)
Grass and pollen (7)
Guidances (376)
Healthcare (18046)
HIV (54)
Huntington's disease (44)
IgA nephropathy (77)
Immunology and inflammation (260)
Immuno-oncology (40)
Indications (75)
Infectious disease (3184)
Inflammatory bowel disease (184)
Inflation Reduction Act (13)
Influenza (111)
Intellectual property (215)
Interviews (555)
IPO (14731)
IRA (53)
Job creations (3152)
Job search strategy (1900)
Kidney cancer (17)
Labor market (68)
Layoffs (583)
Leadership (37)
Legal (8445)
Liver cancer (94)
Longevity (12)
Lung cancer (638)
Lymphoma (352)
Machine learning (37)
Management (57)
Manufacturing (687)
MASH (168)
Medical device (11943)
Medtech (11980)
Mergers & acquisitions (19035)
Metabolic disorders (1252)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (311)
Neuropsychiatric disorders (80)
Neuroscience (2878)
NextGen: Class of 2025 (6326)
Non-profit (4529)
Now hiring (53)
Obesity (602)
Opinion (304)
Ovarian cancer (152)
Pain (184)
Pancreatic cancer (203)
Parkinson's disease (263)
Partnered (32)
Patents (454)
Patient recruitment (413)
Peanut (55)
People (55587)
Pharmaceutical (33)
Pharmacy benefit managers (23)
Phase I (20949)
Phase II (29703)
Phase III (22534)
Pipeline (3979)
Policy (295)
Postmarket research (2655)
Preclinical (8883)
Press Release (63)
Prostate cancer (218)
Psychedelics (52)
Radiopharmaceuticals (271)
Rare diseases (772)
Real estate (4949)
Recruiting (70)
Regulatory (23849)
Reports (37)
Research institute (2434)
Resumes & cover letters (416)
Rett syndrome (24)
RNA editing (13)
RSV (79)
Schizophrenia (148)
Series A (214)
Series B (161)
Service/supplier (6)
Sickle cell disease (98)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (39)
Startups (3216)
State (2)
Stomach cancer (19)
Supply chain (99)
Tariffs (85)
The Weekly (83)
Vaccines (1083)
Venture capital (74)
Weight loss (417)
Women's health (62)
Worklife (21)
Date
Today (26)
Last 7 days (133)
Last 30 days (1947)
Last 365 days (28797)
2025 (28769)
2024 (33190)
2023 (37384)
2022 (48332)
2021 (52286)
2020 (51133)
2019 (44664)
2018 (33864)
2017 (30816)
2016 (29553)
2015 (34153)
2014 (26539)
2013 (22191)
2012 (23691)
2011 (24547)
2010 (22369)
Location
Africa (898)
Alabama (73)
Alaska (5)
Arizona (227)
Arkansas (12)
Asia (40064)
Australia (7751)
California (9439)
Canada (2944)
China (1016)
Colorado (397)
Connecticut (407)
Delaware (302)
Europe (92708)
Florida (1474)
Georgia (307)
Hawaii (3)
Idaho (59)
Illinois (753)
India (56)
Indiana (455)
Iowa (18)
Japan (380)
Kansas (115)
Kentucky (34)
Louisiana (25)
Maine (59)
Maryland (1250)
Massachusetts (6737)
Michigan (284)
Minnesota (477)
Mississippi (5)
Missouri (120)
Montana (28)
Nebraska (24)
Nevada (107)
New Hampshire (74)
New Jersey (2657)
New Mexico (23)
New York (2563)
North Carolina (1226)
North Dakota (7)
Northern California (4530)
Ohio (268)
Oklahoma (16)
Oregon (30)
Pennsylvania (1960)
Puerto Rico (19)
Rhode Island (36)
South America (1223)
South Carolina (59)
South Dakota (1)
Southern California (3708)
Tennessee (149)
Texas (1501)
United States (34077)
Utah (301)
Vermont (1)
Virginia (242)
Washington D.C. (70)
Washington State (787)
West Virginia (4)
Wisconsin (80)
Wyoming (2)
645,009 Results for "covestro formerly known as bayer materialscience ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
November 7, 2025
·
4 min read
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
December 2, 2025
·
4 min read
Press Releases
Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
November 24, 2025
·
6 min read
Press Releases
RSNA25: Pediatric Study for Bayer’s Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
December 4, 2025
·
6 min read
Layoffs
Bayer Layoffs Continued in Q3 but CEO Says Cuts Should Be ‘Incremental’ Moving Forward
Bayer has let go of about 13,500 employees, including around 5,000 managers, since implementing a new operating model in early 2024. CEO Bill Anderson said in a recent earnings call that he expects a slower rate of headcount reduction moving forward.
November 14, 2025
·
1 min read
·
Angela Gabriel
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
December 4, 2025
·
6 min read
Press Releases
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025
·
23 min read
Press Releases
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
December 4, 2025
·
6 min read
1 of 64,501
Next
